Jasper Therapeutics Inc
JSPR
NASDAQ
Biotechnology
$0.79
USD
-0.07 (-8.46%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $24.49M
Volume 552.0K
Price Target
$2.00 – $2.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $2.00 and a min estimate of $2.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$2.00
-$1.8 vs prior
Implied Upside
+153.2%
-231.7% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Biren Amin | Piper Sandler | Buy | Initiated | 4 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
ACTU
Actuate Therapeutics Inc
$1.01
▲ +3.6%
ATOS
Atossa Therapeutics Inc
$2.60
▲ +1.6%
ALLR
Allarity Therapeutics Inc
$1.37
▲ +0.7%
CELU
Celularity Inc
$0.7000
▲ +0.1%
ABVC
ABVC Biopharma Inc
$0.9000
▼ -6.2%
CLRB
Cellectar Biosciences Inc
$2.60
▲ +4.8%
LGVN
Longeveron Inc
$0.7400
▲ +6.1%
NEUP
Neuphoria Therapeutics Inc
$3.87
▲ +1.0%